sciencedirect.com/science/a...
Piperlongumine synergistically enhanc... - Advanced Prostate...
Piperlongumine synergistically enhances the antitumour activity sorafenib mediating ROS-AMPK activation targeting CPSF7 in liver cancer
Written by
Bigm789
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Bigm789, you have posted a few times on the remarkably diverse anticancer effects along differing signalling pathways of Piperlongumine in various preclinical trials. If you have made any personal decision on dosage and brand of PL, please let us know.
Not what you're looking for?
You may also like...
Piperlongumine inhibits cell growth and enhances TRAIL-induced apoptosis in prostate cancer cells
https://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=5;spage=216;epage=223;aul
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
according to a new study published in Oncogene....
Targeting a single enzyme can kill prostate cancer cells
https://www.news-medical.net/amp/news/20230203/Targeting-a-single-enzyme-can-kill-prostate-cancer-ce
Highly effective targeted therapy for metastatic prostate cancer, using 177Lu-PSMA Radioligand 
